US Codex
Bill
Notes

S. 4261 — what changed

Fixing Our Regulatory Mayhem Upsetting Little Americans Act

From Placed on Calendar Senate to Engrossed in Senate. 1 section amended between Placed on Calendar Senate and Engrossed in Senate.

Sec. 2 Duty-free treatment of imports of infant formula

(a)
added In general— During the 90-day period beginning on the date of the enactment of this Act, infant formula shall enter the United States free of duty and free of quantitative limitation.
(a)
removed Duty-free treatment of infant formula imported from certain countries—
(1)
removed In general— During the 180-day period beginning on the date of the enactment of this Act, infant formula described in paragraph (2) shall enter the United States free of duty and free of quantitative limitation.
(2)
removed Infant formula described— Infant formula is described in this paragraph if the infant formula—
(A)
removed is classified under heading 1901.10 of the Harmonized Tariff Schedule of the United States;
(B)
removed is imported from a country described in paragraph (3); and
(C)
removed was approved by the agency of the government of that country that regulates infant formula.
(3)
removed Countries described— A country described in this paragraph is any of the following:
(A)
removed Australia.
(B)
removed Israel.
(C)
removed Japan.
(D)
removed New Zealand.
(E)
removed Switzerland.
(F)
removed South Africa.
(G)
removed The United Kingdom.
(H)
removed A member country of the European Union.
(I)
removed A member country of the European Economic Area.
(b)
removed Temporary exemptions from FDA requirements—
(1)
removed In general— With respect to any infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a) during the 180-day period beginning on the date of the enactment of this Act—
(A)
removed the requirements under section 412 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a) shall not apply;
(B)
removed such infant formula may be manufactured, processed, packed, or held in a domestic or foreign facility that is not registered under section 415 of such Act (21 U.S.C. 350d);
(C)
removed the requirements under parts 106 and 107 of title 21, Code of Federal Regulations, shall not apply; and
(D)
removed such infant formula shall not be considered to be misbranded or adulterated solely on the basis of not being in compliance with the requirements of such section 412 or 415, or such part 106 or 107.
(2)
removed Notification requirement—
(A)
removed In general— A person who introduces or delivers for introduction into interstate commerce an infant formula pursuant to subsection (a) shall notify the Secretary of Health and Human Services (referred to in this subsection as the “Secretary”) if such person has knowledge which reasonably supports the conclusion that such infant formula—
(i)
removed may not provide the nutrients required by section 412(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(i)); or
(ii)
removed is a product that meets any criterion under section 402(a) of such Act (21 U.S.C. 342(a)), or which otherwise may be unsafe for infant consumption.
(B)
removed Knowledge defined— For purposes of subparagraph (A), the term knowledge as applied to a person subject to such subparagraph means—
(i)
removed the actual knowledge that the manufacturer had; or
(ii)
removed the knowledge which a reasonable person would have had under like circumstances or which would have been obtained upon the exercise of due care.
(3)
removed Recall authority— If the Secretary determines that infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a) is a product described in paragraph (2)(A)(ii), the manufacturer or importer shall immediately take all actions necessary to recall shipments of such infant formula from all wholesale and retail establishments, consistent with recall regulations and guidelines issued by the Secretary.
(4)
removed Clarification— Section 801(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(j)) shall apply with respect to any infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a) during the 180-day period beginning on the date of the enactment of this Act.
(c)
removed Special supplemental nutrition program for women, infants, and children—
(1)
removed Access for WIC beneficiaries— Notwithstanding any other provision of law, any infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a) during the 180-day period beginning on the date of enactment of this Act is eligible for purchase using benefits received under the special supplemental nutrition program for women, infants, and children established by section 17 of the Child Nutrition Act of 1966 (42 U.S.C. 1786).
(2)
removed Waivers—
(A)
removed Definition of covered document— In this paragraph, the term “covered document” means the attachment entitled “Process for State Agency Waiver Requests Related to Shortages” to the letter of the Secretary of Agriculture dated February 18, 2022, entitled “Voluntary Recall of Certain Abbott Powder Formulas, including Similac, Alimentum and EleCare”.
(B)
removed Waivers— During the 180-day period beginning on the date of enactment of this Act, the Secretary of Agriculture may grant any waiver described in the covered document, including with respect to the exchange or issuance, as applicable, of infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a).
(d)
removed List of imported infant formula— The Secretary of Agriculture, in conjunction with the Secretary of Health and Human Services, shall—
(1)
removed maintain a list of all infant formula introduced or delivered for introduction into interstate commerce pursuant to subsection (a) during the 180-day period beginning on the date of enactment of this Act, which shall include, for each infant formula—
(A)
removed the country of origin;
(B)
removed the recommended measurements for mixing or otherwise preparing the infant formula; and
(C)
removed the approved use and marketing status of the infant formula in the country of origin according to the applicable government entity that regulates infant formula in that country; and
(2)
removed make the list maintained under paragraph (1) publicly available on the websites of each of the Department of Agriculture and the Food and Drug Administration.
(b)
renumbered was (6) Infant formula defined— In this section, the term infant formula has the meaning given that term in section 201(z) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)).